Your browser doesn't support javascript.
loading
Lifestyle factors and risk of myeloproliferative neoplasms in the NIH-AARP diet and health study.
Podoltsev, Nikolai A; Wang, Xiaoyi; Wang, Rong; Hofmann, Jonathan N; Liao, Linda M; Zeidan, Amer M; Mesa, Ruben; Ma, Xiaomei.
Affiliation
  • Podoltsev NA; Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT.
  • Wang X; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
  • Wang R; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
  • Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Liao LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Zeidan AM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT.
  • Mesa R; Mays Cancer Center, University of Texas, San Antonio, TX.
  • Ma X; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
Int J Cancer ; 147(4): 948-957, 2020 08 15.
Article in En | MEDLINE | ID: mdl-31904114
The etiology of Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) is largely unknown. We assessed potential associations between lifestyle factors and MPN risk in the NIH-AARP Diet and Health Study. In this prospective cohort with 463,049 participants aged 50-71 years at baseline (1995-1996) and a median follow-up of 15.5 years, we identified 490 MPN cases, including 190 with polycythemia vera (PV) and 146 with essential thrombocythemia (ET). Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Smoking was not associated with MPN risk in the overall cohort, but analyses stratified by sex suggested that smoking increased the risk of MPN in women (former smoker vs. nonsmokers, HR = 1.43, 95% CI: 1.03-2.00, p = 0.03; current smokers vs. nonsmokers, HR = 1.71, 95% CI: 1.08-2.71, p = 0.02). Coffee consumption was inversely associated with the risk of PV (high vs. low intake, HR = 0.53, 95% CI: 0.33-0.84, p-trend < 0.01), but not the risk of ET or MPN overall. Further analysis revealed an inverse association between the amount of caffeine intake and PV risk (high vs. low intake, HR = 0.55, 95% CI: 0.39-0.79, p-trend < 0.01). While the consumption of caffeinated coffee appeared to confer a protective effect against PV, the consumption of decaffeinated coffee did not. This large prospective study identified smoking as a risk factor for MPN in women and suggests that caffeine intake is associated with a lower risk of PV.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Status / Surveys and Questionnaires / Feeding Behavior / Life Style / Myeloproliferative Disorders Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Status / Surveys and Questionnaires / Feeding Behavior / Life Style / Myeloproliferative Disorders Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2020 Type: Article